Investigation in the cannabigerol derivative VCE-003.2 as a disease- modifying agent in a mouse model of experimental synucleinopathy
Ontology highlight
ABSTRACT: Here we explore the striatum transcriptomic effects of alpha-synuclein administration in mice as model of Parkinson´s disease. Moreover, we also explore the neuroprotective effect of cannabonoid-based druga (VCE-003.2) as a potential neuroportective agent in Parkinson´s disease
INSTRUMENT(S): Illumina HiSeq 2000
ORGANISM(S): Mus musculus
SUBMITTER:
PROVIDER: E-MTAB-13768 | biostudies-arrayexpress |
SECONDARY ACCESSION(S): ERP157201
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA